BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23083522)

  • 1. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.
    Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH
    Eur J Radiol; 2013 Feb; 82(2):366-73. PubMed ID: 23083522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Body
    Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
    J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.
    Lin CY; Lin CL; Kao CH
    Eur J Radiol; 2018 Oct; 107():158-165. PubMed ID: 30292261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
    Shen G; Zhang W; Jia Z; Li J; Wang Q; Deng H
    Br J Radiol; 2014 Dec; 87(1044):20140296. PubMed ID: 25348201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis.
    Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH
    Eur J Radiol; 2012 Nov; 81(11):3511-7. PubMed ID: 22305013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G; Sadeghi R; Annunziata S; Lococo F; Cafarotti S; Bertagna F; Prior JO; Ceriani L; Giovanella L
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: a meta-analysis.
    Xu GZ; Zhu XD; Li MY
    Head Neck; 2011 Jan; 33(1):87-94. PubMed ID: 20848421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Lin CY; Chen JH; Liang JA; Lin CC; Jeng LB; Kao CH
    Eur J Radiol; 2012 Sep; 81(9):2417-22. PubMed ID: 21899970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of whole-body [
    Mirshahvalad SA; Kohan A; Metser U; Hinzpeter R; Ortega C; Farag A; Veit-Haibach P
    Eur Radiol; 2024 Jan; 34(1):673-685. PubMed ID: 37535156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
    Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
    Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
    Kim SJ; Lee SW
    J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis.
    Wei J; Pei S; Zhu X
    Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review.
    Liu T; Xu W; Yan WL; Ye M; Bai YR; Huang G
    Radiother Oncol; 2007 Dec; 85(3):327-35. PubMed ID: 18037523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CT.
    Lu YY; Chen JH; Ding HJ; Chien CR; Lin WY; Kao CH
    Nucl Med Commun; 2012 Nov; 33(11):1127-33. PubMed ID: 23000829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
    Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients.
    Chen YK; Su CT; Ding HJ; Chi KH; Liang JA; Shen YY; Chen LK; Yeh CL; Liao AC; Kao CH
    Anticancer Res; 2006; 26(2B):1471-7. PubMed ID: 16619560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients.
    Li J; Xu W; Kong F; Sun X; Zuo X
    Surg Oncol; 2013 Sep; 22(3):151-5. PubMed ID: 23664848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.